Bioelectronics Corp (BIEL)

[TruthBeSaid]

Sales - New Highs:

You are right Wyatt, those > 100 knee patches disappeared quickly. Yeserday the on-line sales had the highest daily figure I have seen: 127 in one day. Here is the latest chart:



It is remarkable how quickly the sales is picking up. We are averaging nearly 100 a day now, on-line alone, starting from ~ 5 3 quarters ago, when I started tracking. 20 fold less than an year. I take a factor 10 to include all retail sales (as estimated from retail-store info from Josh on this board and from numners for Walgreens), so we are doing 100 a day. That is 400K annually. That is 12 M USD in revenue for Boots. Probably 6M in revenue for Bielcorp and ~ 3 M in gross profit (from sales). BIEL is on course to post first profits from operations this year about 500 K- 1 M USD - they are burning ~ 2.5 M USD a year. That is a big thing.No more dilution or borrowing whatsoever. If the sales growth continues, even at a lower rate, the profit can touch 10 M USD. I am not joking, the on-line sales numbers are real that I diligently collect every day. The effects of these sales have to show up in the financial reports soon, or there can be a PR from the company. When that happens, the PPS will take off. When the FAD ruling is finalized the PPS will get another boost. The current fair price in my estimate for this is ~ 1-2c based on UK sales alone. When these pending news items hit the wires, which can happen any time - we will definitely see 1-2 c and well beyond 5-10c. If you are on the fence don't wait any longer. The gains are nearly assured, as sure as it gets.

This does not factor in recoveryRX sales through the new partnership with Braun. These are higher margin products and with 300,000/year knee/hip replacements in UK (per Yankee), where Braun is a big player, if 30% of these use RecoveryRx, that will bring in a few million more in profits. Biecorp. is on the threshold of big profits.

As always, do your DD. I put out what I know in the hope of helping people here. See my past posts about sales, clinical trial results and share price estimates:

my previous sales report

my previous marketcap/PPS estimates

recent clinical study results

recenet FDA reclass.

review these and see what you think. Invest what you can lose, there is no reward without risk. But in BIEL, the risk/reward is hugely favorable. Not many know about all this, hence the low PPS. When it is all out, you lose your advantage.